Jay S Stout is Chief Technology Officer of Immunovant, Inc.. Currently has a direct ownership of 142,186 shares of IMVT, which is worth approximately $3.91 Million. The most recent transaction as insider was on Oct 23, 2024, when has been sold 2,740 shares (Common Stock) at a price of $29.53 per share, resulting in proceeds of $80,912. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 142K
1.89% 3M change
42.19% 12M change
Total Value Held $3.91 Million

Jay S Stout Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 23 2024
SELL
Open market or private sale
$80,912 $29.53 p/Share
2,740 Reduced 1.89%
142,186 Common Stock
Jul 24 2024
SELL
Open market or private sale
$78,088 $27.76 p/Share
2,813 Reduced 1.9%
144,926 Common Stock
Apr 24 2024
SELL
Open market or private sale
$209,207 $28.9 p/Share
7,239 Reduced 4.67%
147,739 Common Stock
Apr 02 2024
BUY
Grant, award, or other acquisition
-
54,978 Added 26.19%
154,978 Common Stock
Apr 17 2023
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock
JSS

Jay S Stout

Chief Technology Officer
New York, NY

Track Institutional and Insider Activities on IMVT

Follow Immunovant, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMVT shares.

Notify only if

Insider Trading

Get notified when an Immunovant, Inc. insider buys or sells IMVT shares.

Notify only if

News

Receive news related to Immunovant, Inc.

Track Activities on IMVT